CGON vs CHRW · rev $4.0M vs P/E 37, rev $8.95B
CG Oncology, Inc. Common stock (CGON) versus CH Robinson Worldwide Inc (CHRW) — a side-by-side from cached financials, not a winner call.
CG Oncology, Inc. Common stock (CGON) is a biotechnology company listed on US.
CH Robinson Worldwide Inc (CHRW) is a integrated freight & logistics company listed on US.
Latest reported CGON revenue for 2025-12-31 was $4.0M. Net income was -$161.0M. Revenue was up 254.7% from 2024-12-31 to 2025-12-31. CGON currently screens at market cap $4.74B.
Latest reported CHRW revenue for 2026-06-30 was $8.95B. Net income was $334.0M. CHRW currently screens at market cap $21.70B and trailing P/E 37.3.
CGON currently screens at market cap $4.74B. CHRW currently screens at market cap $21.70B and trailing P/E 37.3.
Not investment advice. Open the CGON and CHRW stock pages for the full models.
Not investment advice.